comparemela.com

Page 3 - Myositis Association News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TMA welcomes new executive director

Mallinckrodt Announces Publication of Two Journal Manuscripts with Clinical and Economic Evidence for Acthar® Gel (Repository Corticotropin Injection)

Man diagnosed with rare muscular disorder crosses the Cooper to bring awareness

Man diagnosed with rare muscular disorder crosses the Cooper to bring awareness
live5news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from live5news.com Daily Mail and Mail on Sunday newspapers.

Peter Frampton To Receive Award From Myositis Association

Peter Frampton has received his share of awards from the music industry over his long career. But on Saturday, September 9, he'll be honored in a different setting as he receives the Myositis Association's Heroes in the Fight 2023 Patient Ambassador Award during the organization's Annual Patient Concert in San Diego. Frampton revealed his diagnosis with Inclusion Body Myositis (IBM), a degenerative syndrome that has atrophied his muscles, during 2019. He has continued to make music and is even touring, though he now plays sitting down. Frampton tells us that he's learning to live with the limitations the disorder puts on him: "It's not thrilling to have IBM, but on the other hand you adapt and I've adapted and I'm enjoying myself. I have to say this is the best period of my life." :19 (OC: of my life) Frampton recently announced new dates on his Never Say Never Tour, running from November 9th in Louisville, Kentucky to November 22nd in Nashv

Peter Frampton To Receive Award From Myositis Association - Sunny 92 3

Peter Frampton To Receive Award From Myositis Association - Sunny 92 3
sunny923.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sunny923.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.